These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7728650)

  • 1. Ischemic heart disease: bridging the gap between theory and practice.
    Warnica JW
    Can J Cardiol; 1995 Apr; 11 Suppl B():4B. PubMed ID: 7728650
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of helium-neon laser irradiation on myocardial and thyroid functions in patients with ischemic heart disease].
    Ruzov VI; Rubanova MP; Grigor'ev MIu; Cherkunov KV
    Vopr Kurortol Fizioter Lech Fiz Kult; 1997; (5):7-9. PubMed ID: 9446315
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drugs acting on the heart in therapy of silent myocardial ischemia].
    Motz W; Scheler S; Strauer BE
    Internist (Berl); 1992 Oct; 33(10):695-700. PubMed ID: 1358855
    [No Abstract]   [Full Text] [Related]  

  • 4. [Medical treatment for silent myocardial ischemia: comparison of nitrate, calcium antagonist, and beta-blocker].
    Tomita F; Kohya T; Kitabatake A
    Nihon Rinsho; 1994 Aug; 52 Suppl(Pt 2):516-22. PubMed ID: 12440020
    [No Abstract]   [Full Text] [Related]  

  • 5. [The detection of circadian fluctuations in the efficacy of pharmacotherapy in patients with ischemic heart disease using cardiointervalography].
    Arushanian EB; Shamliian TA
    Eksp Klin Farmakol; 1996; 59(2):24-6. PubMed ID: 8974558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Late sodium current and calcium overload--pathogenesis and adequate treatment].
    Jacobshagen C
    Dtsch Med Wochenschr; 2013 Apr; 138(16):842-7. PubMed ID: 23589047
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lipid peroxidation and antioxidant defense system in myocardial ischemia].
    Barsel' VA; Syrkin AL; Eliubaeva ID; Kogan IG; Vakhliaev VD; Aksiutina MS; Arkhipova TV; Shchedrina IS
    Dokl Akad Nauk; 1996 Dec; 351(5):706-8. PubMed ID: 9102090
    [No Abstract]   [Full Text] [Related]  

  • 8. [The hemodynamic status of patients with ischemic heart disease under long-term treatment with calcium antagonists].
    Bychko MV
    Lik Sprava; 1999; (3):62-5. PubMed ID: 10474938
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in indicators of the antioxidant defense system in patients with ischemic heart disease treated conventionally].
    Syrkin AL; Barsel' VA; Alliluev IG; Kogan IG; Aksiutina MS; Eliubaeva ID; Nesmeianova MA; Drozdov DV
    Klin Med (Mosk); 1996; 74(3):24-7. PubMed ID: 8926695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calcium channel blockers in the treatment of ischemic heart disease].
    Bultas J
    Vnitr Lek; 1995 Mar; 41(3):167-8. PubMed ID: 7762171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium channel inhibitors and ventricular filling].
    Dorobantu M; Bounhoure JP
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11):1579-85. PubMed ID: 1300955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing for angina.
    Shetty K
    Practitioner; 1994 Jul; 238(1540):540-2. PubMed ID: 7937508
    [No Abstract]   [Full Text] [Related]  

  • 13. [Calcium antagonists in the therapy of ischemic heart disease].
    Makolkin BI; Vakhliaev VD
    Klin Med (Mosk); 1994; 72(1):4-7. PubMed ID: 8196322
    [No Abstract]   [Full Text] [Related]  

  • 14. Do calcium-channel blockers and glucocorticoids impair no production in ischaemic heart disease patients?
    Giroux M; Ferrières J; Salles JP
    Int J Cardiol; 1997 Nov; 62(2):171-2. PubMed ID: 9431870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rationale of the cardioprotective effect of diltiazem].
    Rapezzi C; Vassallo PL; Paoli G; Branzi A
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):315-8. PubMed ID: 12497927
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of nitrates and slow calcium channel blockers in the treatment of patients with ischemic heart disease and disorders of intraventricular conduction].
    Vorob'ev LP; Maev IV; V'iuchnova ES
    Lik Sprava; 1996; (1-2):62-8. PubMed ID: 9005109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium antagonists and ischemic heart disease].
    Matsuoka H; Imaizumi T
    Clin Calcium; 2005 Oct; 15(10):1623-30. PubMed ID: 16199907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of cardiovascular therapy on risk of the development of ischemia and myocardial infarction in the postoperative period in cancer patients with ischemic heart diseases].
    Stetsenko AE; Kassil' VL; Ushakova TI
    Anesteziol Reanimatol; 2001; (5):55-7. PubMed ID: 11757304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium antagonists and ischemic heart disease].
    Simon K; Vályi P; Szépvölgyi A; Badics A; Böhm T
    Orv Hetil; 1996 Sep; 137(39):2131-6. PubMed ID: 8927361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protection against ischemic damage during percutaneous coronary angioplasty].
    Specchia G; Ghio S; Bramucci E; Angoli L; Raffaghello S; De Servi S
    Cardiologia; 1991 Dec; 36(12 Suppl 1):215-20. PubMed ID: 1688158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.